Skip to content

Application of MarteMeo® Counselling to people with behavioral variant frontotemporal dementia and their caregivers - A feasibility study

Application of MarteMeo® Counselling to people with behavioral variant frontotemporal dementia and their caregivers - A feasibility study - AMEO - FTD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014377
Enrollment
5
Registered
2018-04-11
Start date
2016-07-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

behavioural variant frontototemporal dementia (bvFTD)

Interventions

Group 1: The study uses a quasi-experimental one-arm-pre-post-design with double pre-measurement and an embedded mixed-method approach. Five dyads, consistng of a person with behavioural variant Front

Sponsors

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) - Standort Witten
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - the presence of a bvFTD (behavioral variant Frontotemporal Dementia) diagnosis in the family member to be cared for, diagnosed by aspecialist - the dyad (relative with dementia, caregiver) lives together in a household or spends at least four hours a day time together on average - the relative caring for the person with bvFTD is the primary caregiver - the dyad is living in Central Germany

Exclusion criteria

Exclusion criteria: - insufficient knowledge of German - parallel participation of the primary caregiver in another intervention study - presence of a serious psychiatric illness of the primary caregiver - presence of a different form of FTLD (Frontotemporal lobar degeneration) of the person with dementia than bvFTD

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is the dyadic quality of relationship between the person with bvFTD (behavioral variant Frontotemporal Dementia) und his/her primary caregiver and will be measured at T0, T1 and T2 by questionnaire (rating of the primary caregiver).

Secondary

MeasureTime frame
The following secondary outcomes will be measred at T0, T1 and T2: - positive and negative affect of the Person with dementia (proxy rating by primary caregiver) - challenging behaviour of the Person with bvFTD (behavioral variant Frontotemporal Dementia) (proxy rating by primary caregiver) - sensitiveness of the primary caregiver of the person with bvFTD (video sequences will be rated by researchers by means of an observation instrument)

Countries

Germany

Contacts

Public ContactMartin Berwig

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. ((DZNE) - Standort Witten

martin.berwig@dzne.de+49 (0)2302 926 232

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 19, 2026